What is the prevalence of Common Variable Immunodeficiency?

Common Variable Immunodeficiency (CVID) is estimated to affect between 1 in 25,000 and 1 in 50,000 individuals worldwide, though these figures are likely underestimates due to significant diagnostic delays. As a primary immunodeficiency disorder, Common Variable Immunodeficiency is classified as a rare disease that impacts both children and adults, often requiring years of clinical investigation before an accurate diagnosis is reached.

What is the prevalence and incidence of Common Variable Immunodeficiency?

While precise global incidence data for Common Variable Immunodeficiency is difficult to capture, prevalence is generally cited between 2 and 5 per 100,000 people in North America and Europe. Because many patients remain asymptomatic for years or are misdiagnosed with recurrent infections, the true prevalence of Common Variable Immunodeficiency is likely higher than current clinical registries suggest. Currently, 22 people with Common Variable Immunodeficiency have joined the DiseaseMaps.org community, providing a real-world perspective on the diagnostic journey.

Who is most affected by Common Variable Immunodeficiency?

Common Variable Immunodeficiency affects males and females with roughly equal frequency. Regarding age of onset, the condition is notable for its bimodal distribution:

• Pediatric onset: A smaller peak occurs in early childhood, often between ages 1 and 5.


• Adult onset: A larger, more common peak occurs during the second and third decades of life (ages 20–40).


• Ethnicity: While CVID is found globally, some studies suggest a slightly higher diagnostic prevalence in populations of European descent, though this may reflect healthcare access disparities rather than biological susceptibility.

Why is accurate data for Common Variable Immunodeficiency challenging to obtain?

The primary barrier to understanding the true scope of Common Variable Immunodeficiency is the significant "diagnostic gap." Patients often experience a delay of 6 to 7 years from the onset of symptoms to an official diagnosis. During this time, individuals may be treated for isolated infections without the underlying immune deficiency being identified. Furthermore, because Common Variable Immunodeficiency has a highly variable clinical presentation, it is frequently confused with other autoimmune or inflammatory conditions.

Next steps

• Consult an immunologist or a specialist in primary immunodeficiency disorders for formal testing.


• Join the DiseaseMaps.org community to connect with other patients living with Common Variable Immunodeficiency.


• Maintain a detailed log of your infection history and symptoms to assist your physician in the diagnostic process.


• Visit the Immune Deficiency Foundation (IDF) website for up-to-date resources and patient support programs.

Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment.

References

• Orphanet: Common Variable Immunodeficiency (ORPHA:459).


• NIH Genetic and Rare Diseases Information Center (GARD): Common Variable Immunodeficiency.


• Immune Deficiency Foundation (IDF): Understanding CVID.


• OMIM (Online Mendelian Inheritance in Man): Common Variable Immunodeficiency (Entry #240500).